Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. - Wikidata - awgldk - TriplyDB

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

http://www.wikidata.org/entity/Q35197060

about

Genetic background in nonalcoholic fatty liver disease: A comprehensive review Interferon-λ: Immune Functions at Barrier Surfaces and Beyond A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection Zinc is a potent and specific inhibitor of IFN-λ3 signalling.Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types.The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors Duplex High-Resolution Melting Assay for the Simultaneous Genotyping of IL28B rs12979860 and PNPLA3 rs738409 Polymorphisms in Chronic Hepatitis C Patients Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells.Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.Cytokine levels contribute to the pathogenesis of minimal hepatic encephalopathy in patients with hepatocellular carcinoma via STAT3 activation.Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease.Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.Type III Interferons in Hepatitis C Virus Infection.Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort.New perspectives of biomarkers for the management of chronic hepatitis B.Interferon Lambda: Modulating Immunity in Infectious Diseases.Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection.Genetic and epigenetic mechanisms of NASH.Targeting IFN-λ: therapeutic implications.Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.A systematic review and meta-analysis of HCV clearance.The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.IFNL4 rs368234815 TT>δG Variant is Associated with Liver Damage in Patients with Non-alcoholic Fatty Liver Disease.Relationship of Genotype for HLA B*57 and IFNL4 with Disease Progression in Female HIV Controllers.IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study.Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes.

P2860

Q26780248-816CD4F3-E096-4DD2-9EFD-ECE277F96781 Q26801049-DEC422CB-C049-4CE6-BA9A-D1C836924442 Q33632714-E0FFB5BB-59F4-400B-8499-FA7CC75AADB3 Q33720876-3633136F-BDB1-42BF-864C-A382E135E1BC Q33898567-8E0B1662-307E-42BB-AFF8-98801A2AFA44 Q34504772-2F92107E-8016-4F22-914D-75AFC2D50C8C Q35849638-1365A835-6A3C-47A1-A9FB-F9BB2C72DC20 Q36134478-094FD075-C15A-4DFB-948A-0921CF034625 Q36155389-70B6A310-F0E7-4A80-8335-34199EE0A266 Q36184217-93BB0B7A-6592-497C-AF5D-FC0FAF6A5344 Q36201137-FAD134CB-0B38-418F-9324-B2FD70053109 Q36274463-E2618B18-7B81-4313-8A8C-2118E92F570A Q36316508-446220B7-4A19-474A-A73F-72FF0F21D5A3 Q36406176-55E9C212-B203-4A7B-962F-549502A6CC4C Q36499677-3BCCCC12-84F4-4F62-A0F8-BFCC9E5AC2DD Q36511162-251598D2-8E5F-4038-8A5C-B8B09EA12F99 Q36871793-571E02DD-7F4A-444C-A3B0-A39D33DF07D3 Q36921188-F0F2EE4D-DF11-470C-A47E-F12DEF2BAA06 Q37003049-1D8E3904-330C-4B56-940C-DA82D7E63B2A Q37087800-5D503768-5084-4C16-B59E-301D82BE69C1 Q37146192-5A08D628-06FB-49E8-AD53-DF1CE39BFF6B Q37264708-D94B73C1-F2A3-43C6-B34A-414881C0D828 Q37528605-D52D7B6B-B3E5-4836-9474-4A8BD4BED0A3 Q37546867-49203D56-A04D-47B4-A616-5671171E83ED Q37606546-23DD0D96-5005-4A2D-930C-6065C0CE4209 Q37670446-962BC7E3-21D8-4BA8-9194-C9BDC6177328 Q38668279-C633DFDB-6213-45CA-92D9-86A4003AE413 Q38673496-99328A35-40E6-4D43-A425-7F9C7B09B572 Q38816811-143F8A76-59AC-44B0-A6B0-BBAD14F2A62F Q38859455-ABC8BBBF-CC5B-499E-840B-E2D10B37FCD9 Q38928083-8589E28F-5CEF-4713-AE16-D2CA5AB489A5 Q39008629-9527D363-26B6-4EDB-9E64-04341EA88AD2 Q40098532-42940C82-5CB6-4BA0-86C7-1E4A2D81C18D Q40121061-09253DA6-3254-4A4E-8044-FEB70F926355 Q40186760-B0A7C2B6-E621-463D-913F-C44BB1950CB4 Q40258100-C3959EAD-74AE-47C6-A9AA-E112155CD7AF Q40330653-DB642962-7201-4EC9-8F17-8EACF61A5F02 Q40390455-3E321880-1CD0-45D5-8F25-782D9F13030F Q40483611-475A4CEF-A6E7-43C2-8E1E-A7F651B5197C Q40813737-E4B60B95-8117-42A6-9B0C-17060DEB6232

P2860

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

http://www.wikidata.org/entity/Q35197060

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Interferon-λ rs12979860 genoty ...... n-viral chronic liver disease.

@ast

Interferon-λ rs12979860 genoty ...... n-viral chronic liver disease.

@en

type

label

Interferon-λ rs12979860 genoty ...... n-viral chronic liver disease.

@ast

Interferon-λ rs12979860 genoty ...... n-viral chronic liver disease.

@en

prefLabel

Interferon-λ rs12979860 genoty ...... n-viral chronic liver disease.

@ast

Interferon-λ rs12979860 genoty ...... n-viral chronic liver disease.

@en

P1433

Q35197060-2A945793-9955-43AE-B6FB-56BA582EADFC

P1476

Q35197060-C0BDA0EE-1E86-4DCA-A8FD-47F670ADC880

P2093

Q35197060-07FF9486-7CE8-459D-909E-67AEE3415BF5

Q35197060-13B2AC31-35B7-47ED-9DBD-F4D0B0FCD9C7

Q35197060-15DEAA8B-CE42-459D-880C-CAAA485408DA

Q35197060-164D9155-03C1-4260-B2C8-778670C19AC3

Q35197060-3A474C39-CC7C-4ABE-B998-A07B64C79A6E

Q35197060-3FB081C7-4635-4179-82D9-E31E6F7D2A50

Q35197060-454B2A37-5D31-4826-96F3-D31EA9D743E0

Q35197060-50860CF1-2FAE-4CC2-8455-44C7E0D74592

Q35197060-65C2B350-9C47-4F9C-AC55-DB091F87E844

Q35197060-807BE2D9-ACCA-45D1-969C-C9402E3D630F

P2860

Q35197060-07B0272D-255D-480A-945C-25511F923CF3

Q35197060-081F9AE0-8C27-45C4-8172-A900B5716BD8

Q35197060-115FE7B0-FA82-475C-BB1C-2624A170EDBB

Q35197060-1ADD8068-E8C0-4606-AC3F-826F715912A7

Q35197060-1B948F4B-0132-4EF1-9E1A-99E3388AD1A7

Q35197060-2C83C3B4-DA73-45E6-924E-FC987CF78AD6

Q35197060-2F7F35E7-0AF0-4505-9BAF-7C2CBEE1C2A8

Q35197060-3094C7F9-BDAF-4088-90FD-93B315719453

Q35197060-3DB087BF-E835-4C90-8028-7738EDDB1058

Q35197060-3E16739F-ED12-4CC3-9472-1988EE365433

P2888

Q35197060-0C81FC0F-9229-4BB8-AE91-F3D34B221E0D

P304

Q35197060-2488D156-3B18-42FE-ADB2-646F568B21A3

P31

Q35197060-46BBD541-E7DC-4727-BD43-3003C59B8AC2

P356

Q35197060-51E61331-D5D3-41C5-A283-3CBF229F62C5

P407

Q35197060-9D02E6C3-21C0-4437-A8B6-4C92D9F806A0

P478

Q35197060-B8531704-4796-49D9-855F-AF972D9205D7

P50

Q35197060-1F5CFED5-B934-4E81-B5C0-0F78F14D2A24

Q35197060-229C77EB-3E2C-4B48-B0F2-A90A6C4DAE9C

Q35197060-66EEEB80-3793-4C08-A0BF-F9B691A337E1

Q35197060-74A71D43-B885-41E9-BED9-86737321B5E1

Q35197060-8B240950-B6E5-49B2-9EC7-3DBCDBD5C8BD

Q35197060-92E9206B-7D37-4052-92B0-9A21861A6601

Q35197060-BD134AAD-B5A1-47C1-94BA-F555E2511BED

Q35197060-BFA30FB9-ED59-4EA7-9CC8-FAFAC5FD7066

P577

Q35197060-7E146700-9056-4094-BF73-268727CC1295

P5875

Q35197060-609D017E-3D80-413F-8395-8B89E438FCF1

P698

Q35197060-7B16FB43-B1D9-4576-95DE-F32F5EBD8EF6

P932

Q35197060-6A867335-846F-4F31-B809-78E5F8FAE80A

P356

P1433

Nature Communications

P1476

Interferon-λ rs12979860 genoty ...... on-viral chronic liver disease

@en

P2093

Ahmed M Hashem

http://www.w3.org/2001/XMLSchema#string

Alessandra Mangia

http://www.w3.org/2001/XMLSchema#string

Christopher Liddle

http://www.w3.org/2001/XMLSchema#string

David R Booth

http://www.w3.org/2001/XMLSchema#string

Duncan McLeod

http://www.w3.org/2001/XMLSchema#string

Elisabetta Bugianesi

http://www.w3.org/2001/XMLSchema#string

Gregory J Dore

http://www.w3.org/2001/XMLSchema#string

Henry L K Chan

http://www.w3.org/2001/XMLSchema#string

International Hepatitis C Genetics Consortium (IHCGC)

http://www.w3.org/2001/XMLSchema#string

Jacob George

http://www.w3.org/2001/XMLSchema#string

P2860

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

Cellular and molecular mechanisms of fibrosis

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Genetic heterogeneity in human disease

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

P2888

P304

6422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS7422

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth Powell

Olfat G. Shaker

Golo Ahlenstiel

William L. Irving

Manuel Romero-Gomez

Nicola J Armstrong

P577

2015-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273149438

http://www.w3.org/2001/XMLSchema#string

P698

25740255

http://www.w3.org/2001/XMLSchema#string

P932

4366528

http://www.w3.org/2001/XMLSchema#string